Hi
I’m travelling atm, so no time to type too much.
I wanted to point out a few things in response to your post.
1. Forecast revenue includes a buffer for deferral of more San Quintin revenue (large part of original $95m) to be recognised in 2018. This is timing only, so more will be recognised in 2019.
2. Not all US$95m will be recognised as revenue in 2018, and there will likely be a large backlog to carry forward to 2019. If they match $95m, that means they forecast to win well over $100m in revenue in 2018. However only a fraction will be recognised in time for 2018.
3. Cash burn for the next quarter is gross in the 4C, it is offset by the large PDVDS $43m inflow. So you are not correct in offsetting the $25m outflow against the $33m. They have plenty of cash, there is little risk of a cap raising in 2018 or 2019.
- Forums
- ASX - By Stock
- FLC
- Ann: Appendix 4C - quarterly Q4 and Commentary
Ann: Appendix 4C - quarterly Q4 and Commentary, page-31
Featured News
Add FLC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
-0.002(2.50%) |
Mkt cap ! $83.23M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.7¢ | $11.81K | 151.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 45629 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 94663 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 45629 | 0.076 |
2 | 89000 | 0.075 |
1 | 6756 | 0.074 |
1 | 5000 | 0.072 |
1 | 100000 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 94663 | 3 |
0.081 | 74218 | 2 |
0.082 | 50000 | 1 |
0.085 | 139000 | 3 |
0.091 | 77370 | 1 |
Last trade - 14.37pm 18/11/2024 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online